ISSN 2073–4034
eISSN 2414–9128

Interferon Therapy Of Chronic Viral Hepatitis In Children

A.S. Potapov, N.L. Pahomovskaya, G.V. Bolynets, T.S. Chetkina

Interferon therapy of chronic viral hepatitis in children
We presented the experience of Roferon-A (recombinant alfa-2a interferon) administration in 69 children with chronic hepatitis C. The data analysis shows the initial remission occur in 49-61% of children at the end of therapy. Remission in 12 months after completion of treatment remained at 22.8-29.6% of patients. It is emphasized that the hitting probability of prolonged remission significantly increases in case of HCV RNA elimination in early stages of interferon therapy.

Keywords

chronic viral hepatitis C
interferon therapy
Roferon-A
children

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.